Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 42 $ 32
Costs of goods sold 0 0
Gross profit 42 32
Operating expenses:    
Research and development 2,209 2,941
Selling, general, and administrative 2,296 3,180
Total operating expenses 4,505 6,121
Loss from operations (4,463) (6,089)
Interest, net (21) (17)
Non-operating income (expenses) (910) 487
Loss before income taxes (5,394) (5,619)
Income taxes 0 0
Net loss $ (5,394) $ (5,619)
Earnings Per Share, Basic $ (1.09) $ (1.34)
Earnings Per Share, Diluted $ (1.09) $ (1.34)
Weighted Average Number of Shares Outstanding, Basic 4,940,693 4,202,011
Weighted Average Number of Shares Outstanding, Diluted 4,940,693 4,202,011
Anti-dilutive stock options, restricted stock units, performance stock units, and common stock warrants 1,826,029 1,627,637